Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1661-4917
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer ; volume:69 ; number:1 ; day:25 ; month:2 ; year:2021 ; pages:1-8 ; date:12.2021
Archivum immunologiae et therapiae experimentalis ; 69, Heft 1 (25.2.2021), 1-8, 12.2021
- Urheber
-
Wrona, Ewa
Potemski, Piotr
Sclafani, Francesco
Borowiec, Maciej
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00005-021-00605-w
- URN
-
urn:nbn:de:101:1-2021042221354475863574
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wrona, Ewa
- Potemski, Piotr
- Sclafani, Francesco
- Borowiec, Maciej
- SpringerLink (Online service)
Ähnliche Objekte (12)
Microbiome as a biomarker and therapeutic target in pancreatic cancer
Leukemia inhibitory factor in kultivierten Neuroblastomzellen
Macrophage inhibitory cytokine 1 (MIC-1/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma
Follistatin is a novel therapeutic target and biomarker in FLT 3/ITD acute myeloid leukemia
Identification of novel therapeutic target and prognostic biomarker in matrix metalloproteinase gene family in pancreatic cancer
miR-10a as a therapeutic target and predictive biomarker for MDM2 inhibition in acute myeloid leukemia
Chitosan as possible inhibitory agents and delivery systems in leukemia
Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease
Innovative therapeutic approaches in chronic lymphocytic leukemia
Epigenetic Biomarker and Therapeutic Intervention for Dementia
Concurrent Hairy Cell Leukemia and Chronic Lymphocytic Leukemia: Diagnostic and Therapeutic Implications
Concurrent Hairy Cell Leukemia and Chronic Lymphocytic Leukemia: Diagnostic and Therapeutic Implications
Microbiome as a biomarker and therapeutic target in pancreatic cancer
Leukemia inhibitory factor in kultivierten Neuroblastomzellen
Macrophage inhibitory cytokine 1 (MIC-1/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma
Follistatin is a novel therapeutic target and biomarker in FLT 3/ITD acute myeloid leukemia
Identification of novel therapeutic target and prognostic biomarker in matrix metalloproteinase gene family in pancreatic cancer
miR-10a as a therapeutic target and predictive biomarker for MDM2 inhibition in acute myeloid leukemia
Chitosan as possible inhibitory agents and delivery systems in leukemia
Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease
Innovative therapeutic approaches in chronic lymphocytic leukemia
Epigenetic Biomarker and Therapeutic Intervention for Dementia
Concurrent Hairy Cell Leukemia and Chronic Lymphocytic Leukemia: Diagnostic and Therapeutic Implications
Concurrent Hairy Cell Leukemia and Chronic Lymphocytic Leukemia: Diagnostic and Therapeutic Implications
Microbiome as a biomarker and therapeutic target in pancreatic cancer
Leukemia inhibitory factor in kultivierten Neuroblastomzellen
Macrophage inhibitory cytokine 1 (MIC-1/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma
Follistatin is a novel therapeutic target and biomarker in FLT 3/ITD acute myeloid leukemia
Identification of novel therapeutic target and prognostic biomarker in matrix metalloproteinase gene family in pancreatic cancer
miR-10a as a therapeutic target and predictive biomarker for MDM2 inhibition in acute myeloid leukemia
Chitosan as possible inhibitory agents and delivery systems in leukemia
Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease
Innovative therapeutic approaches in chronic lymphocytic leukemia
Epigenetic Biomarker and Therapeutic Intervention for Dementia
Concurrent Hairy Cell Leukemia and Chronic Lymphocytic Leukemia: Diagnostic and Therapeutic Implications